Karine Souza Da Correggio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karine Souza Da Correggio has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Sherlley Casimiro Onofre
Department of Clinical Analysis, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil
4 shared publications - Aldo von Wangenheim
Federal University of Santa Catarina
3 shared publications - Edward Araujo Júnior
Department of Obstetrics Paulista School of Medicine, Federal University of São Paulo (EPM‐UNIFESP) São Paulo Brazil
3 shared publications - Heron Werner
Department of Fetal Medicine Biodesign Laboratory DASA / PUC Rio de Janeiro Brazil
3 shared publications - Roberto Noya Galluzzo
Division of Tocogynecology , University Hospital Polydoro Ernani of São Thiago, Federal University of Santa Catarina (UFSC) , Florianópolis , Brazil
3 shared publications - Gustavo Yano Callado
Albert Einstein Israelite College of Health Sciences (FICSAE), Albert Einstein Israelite Hospital, São Paulo 05652-900, SP, Brazil
2 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 54 (8) , 1336-1343
Ultrasound-based prediction of fetal hyperinsulinemia: development of a fetal metabolic score
Objectives: Gestational diabetes mellitus (GDM) is associated with fetal hyperinsulinemia, excessive adiposity, and adverse perinatal outcomes; sonographic markers of fetal adiposity, liver enlargement, and septal thickening may allow direct assessment of fetal metabolic adaptation. This study aimed to develop an ultrasound-based fetal metabolic score (FMS) estimating the risk of fetal hyperinsulinemia. Methods: The FMS was developed from a prospective cohort of 223 pregnant women (128 with GDM, 95 controls). Sonographic markers of neonatal hyperinsulinemia were identified using umbilical cord C-peptide above the 75th percentile as the reference outcome: thigh soft tissue thickness, abdominal subcutaneous fat thickness, fetal liver length, and interventricular septal thickness. Odds ratios from logistic regression were converted into weighted integer coefficients, and continuous measurements were categorized by gestational age-adjusted percentiles into a composite score. Results: Fetuses of GDM mothers showed significantly greater abdominal adiposity, liver length, and interventricular septal thickness than controls. Thigh soft tissue thickness (OR 1.62; 95 % CI 1.25–2.09; p<0.001), abdominal subcutaneous fat thickness (OR 1.57; 95 % CI 1.23–1.99; p<0.001), fetal liver length (OR 1.06; 95 % CI 1.02–1.11; p=0.004), and interventricular septal thickness (OR 1.35; 95 % CI 1.01–1.82; p=0.040) independently predicted elevated cord blood C-peptide. The FMS ranged from 0 to 44 points, integrating weighted contributions from adiposity, visceral growth, and cardiac remodeling markers. Conclusions: The FMS is a novel ultrasound-based approach for estimating fetal hyperinsulinemia risk. By integrating multiple manifestations of the fetal metabolic response to maternal hyperglycemia, it may assess fetal metabolic health more comprehensively than conventional biometry alone.
- 25 August 2026
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 54 (8) , 1336-1343
Open AccessUltrasound-based prediction of fetal hyperinsulinemia: development of a fetal metabolic score
Objectives: Gestational diabetes mellitus (GDM) is associated with fetal hyperinsulinemia, excessive adiposity, and adverse perinatal outcomes; sonographic markers of fetal adiposity, liver enlargement, and septal thickening may allow direct assessment of fetal metabolic adaptation. This study aimed to develop an ultrasound-based fetal metabolic score (FMS) estimating the risk of fetal hyperinsulinemia. Methods: The FMS was developed from a prospective cohort of 223 pregnant women (128 with GDM, 95 controls). Sonographic markers of neonatal hyperinsulinemia were identified using umbilical cord C-peptide above the 75th percentile as the reference outcome: thigh soft tissue thickness, abdominal subcutaneous fat thickness, fetal liver length, and interventricular septal thickness. Odds ratios from logistic regression were converted into weighted integer coefficients, and continuous measurements were categorized by gestational age-adjusted percentiles into a composite score. Results: Fetuses of GDM mothers showed significantly greater abdominal adiposity, liver length, and interventricular septal thickness than controls. Thigh soft tissue thickness (OR 1.62; 95 % CI 1.25–2.09; p<0.001), abdominal subcutaneous fat thickness (OR 1.57; 95 % CI 1.23–1.99; p<0.001), fetal liver length (OR 1.06; 95 % CI 1.02–1.11; p=0.004), and interventricular septal thickness (OR 1.35; 95 % CI 1.01–1.82; p=0.040) independently predicted elevated cord blood C-peptide. The FMS ranged from 0 to 44 points, integrating weighted contributions from adiposity, visceral growth, and cardiac remodeling markers. Conclusions: The FMS is a novel ultrasound-based approach for estimating fetal hyperinsulinemia risk. By integrating multiple manifestations of the fetal metabolic response to maternal hyperglycemia, it may assess fetal metabolic health more comprehensively than conventional biometry alone.
- Open Access
- 8 September 2025
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 45 (2) , 301-312
AI ‐Driven Fetal Liver Echotexture Analysis
Objectives: To evaluate the performance of artificial intelligence (AI)‐based models in predicting elevated neonatal insulin levels through fetal hepatic echotexture analysis. Methods: This diagnostic accuracy study analyzed ultrasound images of fetal livers from pregnancies between 37 and 42 weeks, including cases with and without gestational diabetes mellitus (GDM). Images were stored in Digital Imaging and Communications in Medicine (DICOM) format, annotated by experts, and converted to segmented masks after quality checks. A balanced dataset was created by randomly excluding overrepresented categories. Artificial intelligence classification models developed using the FastAI library—ResNet‐18, ResNet‐34, ResNet‐50, EfficientNet‐B0, and EfficientNet‐B7—were trained to detect elevated C‐peptide levels (>75th percentile) in umbilical cord blood at birth, based on fetal hepatic ultrasonographic images. Results: Out of 2339 ultrasound images, 606 were excluded due to poor quality, resulting in 1733 images analyzed. Elevated C‐peptide levels were observed in 34.3% of neonates. Among the 5 CNN models evaluated, EfficientNet‐B0 demonstrated the highest overall performance, achieving a sensitivity of 86.5%, specificity of 82.1%, positive predictive value (PPV) of 83.0%, negative predictive value (NPV) of 85.7%, accuracy of 84.3%, and an area under the ROC curve (AUC) of 0.83 in predicting elevated neonatal insulin levels through fetal hepatic echotexture analysis. Conclusion: AI‐based analysis of fetal liver echotexture via ultrasound effectively predicted elevated neonatal C‐peptide levels, offering a promising non‐invasive method for detecting insulin imbalance in newborns.
- 8 September 2025
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 45 (2) , 301-312
Open AccessAI ‐Driven Fetal Liver Echotexture Analysis
Objectives: To evaluate the performance of artificial intelligence (AI)‐based models in predicting elevated neonatal insulin levels through fetal hepatic echotexture analysis. Methods: This diagnostic accuracy study analyzed ultrasound images of fetal livers from pregnancies between 37 and 42 weeks, including cases with and without gestational diabetes mellitus (GDM). Images were stored in Digital Imaging and Communications in Medicine (DICOM) format, annotated by experts, and converted to segmented masks after quality checks. A balanced dataset was created by randomly excluding overrepresented categories. Artificial intelligence classification models developed using the FastAI library—ResNet‐18, ResNet‐34, ResNet‐50, EfficientNet‐B0, and EfficientNet‐B7—were trained to detect elevated C‐peptide levels (>75th percentile) in umbilical cord blood at birth, based on fetal hepatic ultrasonographic images. Results: Out of 2339 ultrasound images, 606 were excluded due to poor quality, resulting in 1733 images analyzed. Elevated C‐peptide levels were observed in 34.3% of neonates. Among the 5 CNN models evaluated, EfficientNet‐B0 demonstrated the highest overall performance, achieving a sensitivity of 86.5%, specificity of 82.1%, positive predictive value (PPV) of 83.0%, negative predictive value (NPV) of 85.7%, accuracy of 84.3%, and an area under the ROC curve (AUC) of 0.83 in predicting elevated neonatal insulin levels through fetal hepatic echotexture analysis. Conclusion: AI‐based analysis of fetal liver echotexture via ultrasound effectively predicted elevated neonatal C‐peptide levels, offering a promising non‐invasive method for detecting insulin imbalance in newborns.
- Open Access
- 8 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (16) , 1989
Prenatal Ultrasonographic Markers of Macrossomia and C-Peptide in Gestational Diabetes Mellitus: A Prospective Cohort Study
Objective: To investigate the association between prenatal ultrasonographic markers of macrossomia and C-peptide, a neonatal hyperinsulinemia marker, in pregnancies complicated by gestational diabetes mellitus (GDM), with a focus on fetal adipose tissue thickness, liver length, and interventricular septal thickness. Methods: This prospective cohort study included 223 pregnant women followed from 28 to 36 weeks of gestation in two referral centers in Brazil. The GDM group and matched controls underwent serial ultrasound assessments of fetal biometry, including thigh, abdominal, and subscapular skinfolds, fetal liver length, and interventricular septum thickness. Neonatal hyperinsulinemia was assessed using umbilical cord C-peptide levels. Statistical analyses included t-tests, chi-square tests, correlation analyses, and multivariate logistic regression. Results: Fetuses of mothers with GDM exhibited significantly greater abdominal [t(221) = −3.999, p < 0.01] and subscapular [t(221) = −2.502, p = 0.02] skinfolds, liver length [t(221) = −3.785, p < 0.01], and interventricular septum [t(221) = −4.781, p < 0.01] thickness. However, umbilical cord C-peptide levels did not differ significantly between groups [t(189) = −1.724, p = 0.09]. Only weak correlations were found between fetal ultrasound markers and C-peptide levels. Among all parameters, subcutaneous tissue thickness showed the highest (ρ = 0.30), though still limited, predictive value. Conclusions: Fetuses of mothers with GDM demonstrated increased measures of liver length, subscapular adiposity, and interventricular septal thickness compared to controls. However, these prenatal biometric markers showed weak correlations with neonatal C-peptide levels.
- 8 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (16) , 1989
Open AccessPrenatal Ultrasonographic Markers of Macrossomia and C-Peptide in Gestational Diabetes Mellitus: A Prospective Cohort Study
Objective: To investigate the association between prenatal ultrasonographic markers of macrossomia and C-peptide, a neonatal hyperinsulinemia marker, in pregnancies complicated by gestational diabetes mellitus (GDM), with a focus on fetal adipose tissue thickness, liver length, and interventricular septal thickness. Methods: This prospective cohort study included 223 pregnant women followed from 28 to 36 weeks of gestation in two referral centers in Brazil. The GDM group and matched controls underwent serial ultrasound assessments of fetal biometry, including thigh, abdominal, and subscapular skinfolds, fetal liver length, and interventricular septum thickness. Neonatal hyperinsulinemia was assessed using umbilical cord C-peptide levels. Statistical analyses included t-tests, chi-square tests, correlation analyses, and multivariate logistic regression. Results: Fetuses of mothers with GDM exhibited significantly greater abdominal [t(221) = −3.999, p < 0.01] and subscapular [t(221) = −2.502, p = 0.02] skinfolds, liver length [t(221) = −3.785, p < 0.01], and interventricular septum [t(221) = −4.781, p < 0.01] thickness. However, umbilical cord C-peptide levels did not differ significantly between groups [t(189) = −1.724, p = 0.09]. Only weak correlations were found between fetal ultrasound markers and C-peptide levels. Among all parameters, subcutaneous tissue thickness showed the highest (ρ = 0.30), though still limited, predictive value. Conclusions: Fetuses of mothers with GDM demonstrated increased measures of liver length, subscapular adiposity, and interventricular septal thickness compared to controls. However, these prenatal biometric markers showed weak correlations with neonatal C-peptide levels.
- 12 July 2024
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 52 (8) , 1121-1128
Available evidence on fetal liver changes detected by ultrasound in pregnant women with gestational diabetes mellitus: Systematic review
The aim of this systematic review was to examine the available scientific literature on ultrasound‐detected fetal liver changes in pregnant women with gestational diabetes mellitus (GDM) and to explore the potential of these markers to inform clinical management and improve outcomes. A total of four articles investigating fetal liver changes in GDM pregnancies were selected. The studies varied in methodology, gestational age studied, and diagnostic criteria for GDM. Fetal liver indices, such as fetal liver length and fetal liver volume, emerged as potential markers for identifying GDM and predicting adverse outcomes. Studies suggest an association between fetal liver changes and GDM, with implications for both maternal glycemic control and fetal metabolic adaptation. Variability in study methodology highlights the need for standardized approaches to assess fetal hepatic indices and their correlation with GDM outcomes.
- 12 July 2024
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 52 (8) , 1121-1128
Available evidence on fetal liver changes detected by ultrasound in pregnant women with gestational diabetes mellitus: Systematic review
The aim of this systematic review was to examine the available scientific literature on ultrasound‐detected fetal liver changes in pregnant women with gestational diabetes mellitus (GDM) and to explore the potential of these markers to inform clinical management and improve outcomes. A total of four articles investigating fetal liver changes in GDM pregnancies were selected. The studies varied in methodology, gestational age studied, and diagnostic criteria for GDM. Fetal liver indices, such as fetal liver length and fetal liver volume, emerged as potential markers for identifying GDM and predicting adverse outcomes. Studies suggest an association between fetal liver changes and GDM, with implications for both maternal glycemic control and fetal metabolic adaptation. Variability in study methodology highlights the need for standardized approaches to assess fetal hepatic indices and their correlation with GDM outcomes.